Clin2
NCT05463471Possibly a fitNot yet recruiting

Comparing saline and albumin for fluid replacement in shock

Shock

Treatments studied

Part of Blood & lymphatic, Heart & circulation clinical trials.

This trial tests whether giving balanced salt solutions (like Ringer's) or albumin (a protein in blood) is better at helping patients in shock regain normal blood pressure and blood flow. It's a common treatment for shock, and this study aims to find which fluid works best.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
500 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 or older.
  • You must be in shock, meaning your body isn't getting enough blood flow, such as cold skin, low urine output, confusion, or high blood lactate (a sign of poor oxygen).
  • Your doctor must confirm your body is likely to respond well to extra fluids (a 'fluid challenge' test).
  • You must not be pregnant or breastfeeding.
  • You must not be receiving ECMO or IABP (heart/lung support machines).
  • You must not have had a recent heart attack or severe heart failure (NYHA class IV).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07373717Enrolling by invitation
Comparing fluid tolerance tests in shock patients

This trial studies different ways to measure how much extra fluid your body can handle when you are in shock. The goal is to see which method works best and helps doctors make better decisions about fluid treatment.

Nanjing, Jiangsu
NCT05888974Recruiting
Test of heart ultrasound to guide fluids in shock

This study checks whether a specific heart ultrasound measurement can help doctors decide if you will benefit from extra fluid during early emergency treatment for shock. It may help avoid unnecessary fluids and support faster, safer decision-making.

Nîmes
NCT02118467Recruiting· Phase 4
Testing medicines that raise blood pressure in ICU shock patients

This trial studies whether “blood pressure–supporting” medicines (given through a central line) work well and safely for adults in the ICU who have shock. Your team may use the results to improve care for people with low blood pressure and poor blood flow to organs.

Chicago, Illinois
NCT05148286Recruiting· Phase 4
Testing albumin vs fluids for septic shock in the ER

This trial tests whether giving albumin instead of standard crystalloid fluids helps adults with septic shock. It may improve how well your body circulates blood and reduces strain on organs.

Seoul
NCT07240701Not yet recruiting· Phase 4
Comparing two IV fluids for initial sepsis treatment

This trial compares two common IV fluids (normal saline and Ringer's lactate) to see which one works better for initial hydration in people with sepsis in the emergency department. It aims to find the safest and most effective way to give fluids early in sepsis treatment.

Kütahya
NCT07212582Not yet recruiting· Phase 3
Albumin for septic shock after surgery

This trial tests whether giving albumin (a protein in the blood) along with standard fluids helps patients with septic shock after a surgical infection. The goal is to see if it improves recovery and survival compared to fluids alone.

Bangkok, Bangkoknoi

Hear when a new Shock trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.